About Kevin Smith
Form D filings for Nanospectra Biosciences from 2020 to 2023 list Kevin Smith as director.
Kevin Smith first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Smith in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Smith works with at each company, as listed on that company's latest Form D.
Nanospectra Biosciences Inc. · Form D, Mar 15, 2023
BS
Blair Shamel
Director
PP
Patrick Pace
Director
BN
Bradley Nyberg
Director
DJ
David Jorden
Chief Executive Officer and director
GG
Glenn Goodrich
Executive officer